Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 26, 2014. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share capital movements.
- Shares Purchased: 126,500 Ordinary Shares of 25 pence each.
- Purchase Date: February 26, 2014.
- Price Range: Highest price paid was 1,694.50 pence per share; lowest price paid was 1,670.00 pence per share.
- Treasury Holdings (Settled): 488,815,169 shares (9.14% of total issued share capital).
- Treasury Holdings (Including Unsettled): 489,055,669 shares (10.07% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,858,531,848 shares.
Material Changes
The filing reports an incremental increase in treasury shares following the purchase of 126,500 shares. Consequently, the percentage of total voting rights held in treasury increased to 10.07% when including unsettled purchases. No other material changes to financial position or operations are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. It is a compliance disclosure regarding share buybacks under the Financial Conduct Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares in issue (4,858,531,848) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the current percentage of voting rights held in treasury (10.07% including unsettled shares).
- Review the price paid per share (1,670.00 to 1,694.50 pence) against market prices on February 26, 2014.
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial statements.